Safety Lancets Market Size, Share & Industry Analysis, By Type (Button-activated and Pressure/Contact-activated), By Incision Type (Needle and Blade), By Age Group (Adult and Pediatric), By Application (Blood Glucose Monitoring, Hemoglobin Testing, Cholesterol Testing, and Others), By End-user (Hospitals & Clinics, Home Care, and Others), and Regional Forecast, 2025-2032

The global safety lancets market size was valued at USD 1.09 billion in 2024. The market is projected to grow from USD 1.21 billion in 2025 to USD 2.60 billion by 2032, exhibiting a CAGR of 11.5% during the forecast period. North America dominated the safety lancets market with a market share of 37.61% in 2024.

Safety lancets are specialized medical devices designed for blood sampling, primarily used in diabetes management and other diagnostic applications. Unlike traditional lancets, this product offers safety features that protect users from accidental needle stick injuries after use. This design enhances safety for both patients and healthcare providers by minimizing the risk of infections and injuries associated with needle use. The adoption of safety lancets is expected to be propelled by the increasing prevalence of diabetes and other chronic diseases, regulatory pressures for safer medical practices, and technological innovations, thereby driving market growth.

The market is highly fragmented, with several key players such as BD, Cardinal Health, HTL-STREFA (MTD Medical Technology and Devices), SARSTEDT AG & Co. KG, and others, increasingly implemented various growth strategies such as acquisitions, new product launches, and geographical expansions to gain a significant portion of the market.

MARKET DYNAMICS

Market Drivers

Increasing Incidence of Diabetes and Chronic Diseases to Boost Demand for Safety Lancets

Over the past few years, there has been a considerable rise in the number of diabetes cases, which is driving the need for several effective products, including safety lancets for the collection of blood samples to determine blood glucose levels.

• For instance, in June 2023, the Institute for Health Metrics and Evaluation reported that over half a billion individuals are living with diabetes across the globe.

Additionally, the increasing preference for home monitoring solutions and the need for convenient, less invasive blood sampling methods are further propelling the use of these products, thus driving the global safety lancets market growth.

Patients are increasingly seeking products that provide a comfortable experience, enhancing compliance with regular testing routines. Therefore, the urgent need for effective diabetes management tools due to the increasing incidence of diabetes and chronic diseases is anticipated to fuel the market expansion in the forthcoming years.

Market Restraints

Cost Concerns May Hinder Safety Lancets Adoption Across the Globe

Despite offering enhanced protection and convenience, safety lancets are often priced higher as compared to other sharp products such as traditional lancets. This price differential acts as a significant barrier to adoption, particularly in developing regions where healthcare budgets are limited and cost-effectiveness is a priority.

• For instance, according to the data published by the NHS in October 2020, the safety lancet typically ranges from around USD 4.87 to USD 5.06 per 100 lancets, while traditional lancets can cost as low as USD 2.37 to USD 4.22 per 100 lancets.

Healthcare providers may hesitate to invest in such devices due to budget constraints, opting for more affordable traditional options. Additionally, patients managing diabetes at home may be deterred by the higher out-of-pocket expenses associated with lancet devices, leading to lower adoption.

In consideration of the high costs associated with safety lancets, healthcare providers and patients may prefer conventional lancets due to familiarity and favorable prices, which can slow the transition to modern options. This is anticipated to limit the market expansion in the upcoming years.

Market Opportunities

Rising Demand for Home Healthcare Monitoring to Augment Market Growth

In recent years, the rising demand for home diagnostics has been creating significant opportunities for lancets. The shift of more patients to manage chronic conditions, particularly diabetes, from home is increasing the need for safe and convenient blood sampling devices such as safety lancets.

• For instance, according to the data published by the Indian Journal of Medical Specialties in December 2023, a study reported that 35.0% out of the 100 patients used glucometer for SMBG at home.

Safety lancets, designed to minimize the risk of needlestick injuries and facilitate self-monitoring, are becoming essential tools due to the rising demand for these devices for home healthcare. Additionally, the simplicity and ease of use of these devices make them ideal for patients who require regular blood tests without professional assistance, which is expected to propel their use among patients.

Moreover, government support and increased funding for home healthcare initiatives are further driving their adoption, which is projected to fuel the market expansion over the forecast period.

Market Challenges

Limited Healthcare Spending in Some Regions Restricts Market Growth

In several developing countries, the under-developed healthcare infrastructure and limited spending on advanced medical devices restrict the availability of effective solutions such as safety lancets. The individuals in these regions often prefer cost-effective products such as traditional lancets due to these economic constraints and limited coverage.

• For instance, according to the data published by ScienceDirect in January 2024, the Bangladesh government spends only 2.34% of the national GDP on the public healthcare system. This expenditure is the lowest among Asia Pacific countries.

Moreover, this low healthcare spending can also limit the import of modern devices in the region, thereby decreasing its access to the population. This makes it difficult for patients to afford the essential products, even when they are crucial for managing conditions, including diabetes.

Additionally, there remains a significant gap in awareness regarding the benefits of using modern devices over traditional options, which may pose a major challenge in the penetration rate of these products.

Safety Lancets Market Trends

Increasing Preference for Automatic Safety Lancets has Emerged as a Key Trend in the Market

Currently, there has been a preferential shift toward automatic/pressure-activated safety lancets over manually activated lancets such as push button and side button lancets. The automatically activated lancets are favored for their enhanced safety features, such as automatic needle retraction, which minimizes the risk of needlestick injuries.

• For instance, according to the study published by the NCBI, in April 2020, automatically activated lancets have been proven to be superior to manually activated lancets in terms of pain and treatment time.

These benefits have made the product particularly important in both clinical and home care settings. Moreover, as healthcare providers increasingly prioritize efficient and safe diagnostic tools, the adoption of automatic lancets is expected to rise during the forecast period.

Request a Free sample to learn more about this report.

IMPACT OF COVID-19

The market witnessed negative growth in 2020 due to the COVID-19 pandemic. This was mainly due to the supply chain disruptions. Moreover, the significant decline in monitoring tests among diabetes patients, such as blood glucose monitoring and the HBA1C tests, led to decreased usage of sharp objects for blood collection, including the safety lancets.

• For instance, according to the data published by NCBI, in February 2021, HBA1C testing significantly reduced to around 66.0% in the first 8 weeks of March and April 2020.

The market also witnessed a decline in 2021 as there was a decline in tests for blood glucose monitoring. Furthermore, the market started to recover in 2022 due increasing volume of self-monitoring of blood glucose and increasing patient visits to diagnostic laboratories as well as hospitals. The market is projected to witness significant growth during the forecast period due to the rising prevalence of diabetes globally and the growing demand for self-monitoring equipment.

Segmentation Analysis

By Type

Button-activated Segment is Expected to Dominate Due to High Demand

Based on type, the market is segmented into button-activated and pressure/contact-activated.

The button-activated segment dominated the market in 2024. Button-activated safety lancets are designed with a straightforward activation mechanism that allows for easy usage, even by individuals with limited training. This accessibility is particularly beneficial in healthcare settings where various personnel may need to perform blood sampling quickly and efficiently. This scenario is driving its adoption, which is expected to boost the segment’s growth.

The pressure/contact-activated segment held a substantial global safety lancets market share in 2024. It often provides a more consistent puncture depth and reduces the risk of accidental needle exposure, making them more effective and safer. These benefits are anticipated to increase their adoption rate over button-activated products in developed regions, thereby boosting the segment’s growth.

• For instance, as of 2025, BD Microtainer contact-activated lancet facilitates a consistent puncture depth for easier sampling.

To know how our report can help streamline your business, Speak to Analyst

By Incision Type

Needle Segment Expected to Dominate Market Due to Superior Safety Features and Lesser Pain

Based on incision type, the market is segmented into needle and blade.

The needles segment held a dominating market share in 2024. This can be attributed to a high preference for needle lancets primarily due to their superior safety features, ease of use, and reduced pain during blood sampling. They cater to users who require frequent testing while minimizing risks associated with needlestick injuries, which is expected to increase their adoption rate in coming years.

• For instance, according to the study published by NCBI, in April 2020, the pain caused by the needle version was less compared to the blade version while obtaining blood samples for testing.

The blade segment is expected to register a substantial CAGR during the forecast period. This is due to the growing application of blade versions for neonatal screening and dried blood spot tests. Moreover, studies have indicated that some blade-equipped lancets can yield higher blood volumes than needle versions, making them suitable for certain diagnostic tests.

• For instance, according to the study published by NCBI in April 2020, the MediSafe Solo type lancet does not have a blade version, resulting in it being associated with the lowest average collected capillary blood volume of 42.4 μL. In contrast, the Acti-Lance and Medlance Plus types, which each feature one blade version, had mean collected capillary blood volumes of 82.2 μL and 99.0 μL, respectively.

By Age Group

Adult Segment to Dominate Market Due to Higher Demand for Various Applications

Based on age group, the market is segmented into adult and pediatric.

The adult segment held a dominating market share in 2024. This can be due to the increasing HbA1c or glycated hemoglobin testing, as well as cholesterol and coagulation testing. Moreover, the increasing blood glucose monitoring in type 2 diabetic patients who are on insulin therapy is also driving the adoption of safety lancets among adults.

The pediatric segment is expected to register a substantial CAGR in the forthcoming years. This segmental growth is due to the high usage of safety lancets among type 1 diabetes children and adolescents to monitor blood glucose daily. Moreover, the recommendation of self-monitoring of blood glucose by healthcare organizations is also expected to surge the utilization of such devices among pediatrics.

• For instance, according to the guidelines of the NHS.UK, individuals with Type 1 diabetes (T1DM) must perform self-testing four times a day (at least five times a day for children) to gain optimal control, avoid hypoglycemia, and avoid metabolic emergencies such as diabetic ketoacidosis.

By Application

Increasing Prevalence of Diabetes to Drive the Blood Glucose Monitoring Segment

Based on application, the market is segmented into blood glucose monitoring, hemoglobin testing, cholesterol testing, and others.

The blood glucose monitoring segment dominated the market in 2024. This dominance is mainly attributed to the rising prevalence of diabetes worldwide and the growing adoption of safety lancets for blood glucose testing, as recommended by healthcare professionals to avoid further complications and control the disease effectively.

• For instance, as of 2025, the projections from the International Diabetes Federation (IDF) reported that 1 in 8 adults, approximately 783 million, will be living with diabetes by 2045.

The hemoglobin testing segment is expected to grow at the fastest CAGR over the forecast period. This growth is attributed to a rise in global HbA1c testing among diabetes patients, which involves a finger prick test driving the demand for safety lancets.

The cholesterol testing segment held a moderate market share in 2024 due to the growing demand for common routine health checks for cholesterol levels that involve the use of sharp objects such as lancets.

The others segment is anticipated to witness significant growth during the forecast period. This growth can be attributed to the increasing use of safety lancets in dried blood spot tests, coagulation monitoring, lipid profiling, and others.

By End-user

Hospitals & Clinics to Lead Due to Higher Number of Hospitals of Patient

Based on end-user, the market is segmented into hospitals & clinics, home care, and others.

The hospitals & clinics segment held a dominating share in 2024 due to an increase in the number of patient visits to hospitals for diabetes testing. This is increasing the number of Assisted Monitoring of Blood Glucose (AMBG) in these settings that can involve the use of safety lancets for collecting blood samples.

The home care segment is anticipated to register the highest CAGR due to increasing SMBG users worldwide that use 3-4 lancets daily for blood glucose monitoring, especially in type 1 diabetes, due to its proven efficacy. Moreover, the growing availability of other home-use kits, such as HbA1c testing kits, includes a safety lancet for obtaining blood samples.

• For instance, according to the article published by NCBI in June 2024, a research study, mainly from high-income nations, has demonstrated that self-monitoring of blood glucose (SMBG) is effective in managing diabetes mellitus (DM).

The others segment, including blood banks, diagnostic and pathology laboratories, academic institutes, and nursing homes, are anticipated to grow considerably due to the increasing applications such as blood group typing, DBS, HbA1c, lipid profiling, bilirubin testing, and others.

SAFETY LANCETS MARKET REGIONAL OUTLOOK

The market is categorized by geography into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Request a Free sample

North America to Dominate Global Market Owing to High Incidence of Diabetes

North America dominates the market and was valued at USD 0.41 billion in 2024. The strong demand for safety lancets among U.S. individuals, due to the high incidence of diabetes in the region is attracting the prominent market players and increasing the supply of such products in the region, which is anticipated to boost the market growth.

In the U.S., the significant reimbursement for blood glucose monitoring products, including lancets, is significantly driving the sale of these products, thereby driving the country’s market growth. For instance, as of 2025, Medicare Preventive Services for Diabetes Part B covers blood sugar self-testing equipment and supplies, including 300 lancets every 3 months for patients who use insulin.

Moreover, in Canada, the growing awareness programs and increasing key players’ focus on expanding product reach are anticipated to boost the country's market growth.

Europe

The market in Europe accounted for a substantial CAGR due to a well-organized healthcare infrastructure in key countries such as the U.K. and Germany. The high purchase rate of safety lancets by regions major hospitals is increasing the penetration rate of products in the region, which is anticipated to boost the regional market growth.

• For instance, in October 2020, NHS Somerset declared that around USD 13.42 million were spent on safety lancets across England and Wales.

Asia Pacific

Asia Pacific is expected to showcase the highest CAGR due to the strong demand and supply of safety lancets from key countries such as China, India, and South Korea and the highest population with type 2 diabetes in the region. Moreover, the expanding number of domestic manufacturers is also driving product penetration in the region, thus supporting market growth.

• For instance, as of June 2025, according to the data published by the World Health Organization (WHO), there are around 77.0 million above the age of 18 years suffering from type 2 diabetes in India.

Latin America

The Latin American market is expected to grow at a significant CAGR during the forecast period due to the increasing healthcare expenditure and rising demand for home diabetes monitoring influenced by the significant disease burden in the region. This is driving product adoption and boosting the regional market growth.

• For instance, according to the Journal of Diabetology & Metabolic Syndrome in January 2025, type 2 diabetes mellitus (T2D) has become a major health concern with a rising prevalence in Brazil. This may require daily glucose level monitoring involving the use of safety lancets.

Middle East & Africa

Middle East & Africa is anticipated to register stagnant growth during the forecast period. The growth of the region is primarily attributed to the increasing awareness of diabetes management and favorable government policies, which may fuel the demand for diabetes monitoring products such as safety lancets.

• For instance, as per the article published by the South African Medical Research Council in November 2024, the South African government has implemented various policies aimed at addressing non-communicable diseases (NCDs), with a particular focus on diabetes.

COMPETITIVE LANDSCAPE

Key Market Players

Strong Operating Network and Focus on Strategic Initiatives Led to Dominance of HTL-STREFA, BD, and Abbott

The competitive landscape of the global market is fragmented, with established players dominating the market such as HTL-STREFA, BD, and Abbott. The focus of these key players on increasing product supply globally, launching new products, and signing distribution agreements is anticipated to contribute to their growing revenue share.

• In January 2025, BD announced expanded investments in its U.S. manufacturing network to increase production capacity for essential medical devices, such as syringes, needles, and IV catheters, in order to address the ongoing demands of the nation's healthcare system.

Also, a strong focus on strategic initiatives to increase product portfolio and awareness among healthcare providers and patients is expected to create a strong foothold in the market.

The other key market players operating in the market are Cardinal Health, B. Braun SE, Terumo Medical Corporation, SARSTEDT AG & Co. KG, and YPSOMED. These players are focusing on product advancements and geographic expansion to increase their product reputation and brand presence globally.

LIST OF KEY SAFETY LANCET COMPANIES PROFILED

• BD (U.S.)


• SARSTEDT AG & Co. KG (Germany)


• Greiner Bio-One International GmbH (Germany)


• HTL-STREFA (MTD Medical Technology and Devices) (Poland)


• Terumo Medical Corporation (Japan)


• B. Braun SE (Germany)


• Abbott (U.S.)


• Cardinal Health (U.S.)


• YPSOMED (Switzerland)


• Biosense Technologies Private Limited (India)

KEY INDUSTRY DEVELOPMENTS

• November 2024 – Sterilance Medical (Suzhou) Inc. participated in MEDICA 2024 in Germany to showcase its innovative product range.


• May 2021 – Owen Mumford obtained a national group purchasing agreement for safety phlebotomy and specimen collection products with Premier, Inc.


• May 2021 – Owen Mumford introduced the Unistik Touch family of safety lancets to achieve up to 500 μl of blood.


• June 2021 – Sterilance Medical (Suzhou) Inc.’s SteriHeel Plus, a disposable safety heel incision lancet, won the China Patent Excellence Award.


• January 2019 – MediPurpose entered into an agreement with Premier Inc. to include SurgiLance safety lancets.

REPORT COVERAGE

The research report provides a detailed analysis of the market and focuses on key aspects, such as leading companies, competitive landscape, type, incision type, age group, applications, and end-user. Additionally, it offers market dynamics and insights into the latest market trends and highlights key industry developments. In addition to the factors mentioned above, it encompasses several factors that have contributed to the growth of the market in recent years.

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation